🇺🇸 FDA
Patent

US 7563918

Solid and crystalline ibandronate sodium and processes for preparation thereof

granted A61PA61P19/08A61P19/10

Quick answer

US patent 7563918 (Solid and crystalline ibandronate sodium and processes for preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P19/08, A61P19/10, A61P3/00, A61P35/00